Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Colorectal Neoplasms

  Free Subscription


Articles published in Oncol Rep

Retrieve available abstracts of 121 articles:
HTML format
Text format



Single Articles


    March 2017
  1. YUAN Z, Shi X, Qiu Y, Jia T, et al
    Reversal of P-gp-mediated multidrug resistance in colon cancer by cinobufagin.
    Oncol Rep. 2017;37:1815-1825.
    PubMed     Text format     Abstract available


    February 2017
  2. YUAN X, Sun X, Shi X, Wang H, et al
    USP39 promotes colorectal cancer growth and metastasis through the Wnt/beta-catenin pathway.
    Oncol Rep. 2017 Feb 15. doi: 10.3892/or.2017.5454.
    PubMed     Text format     Abstract available


  3. DAI X, Liu J, Nian Y, Qiu MH, et al
    A novel cycloartane triterpenoid from Cimicifuga induces apoptotic and autophagic cell death in human colon cancer HT-29 cells.
    Oncol Rep. 2017 Feb 14. doi: 10.3892/or.2017.5444.
    PubMed     Text format     Abstract available


  4. SHEN T, Yang Z, Cheng X, Xiao Y, et al
    CXCL8 induces epithelial-mesenchymal transition in colon cancer cells via the PI3K/Akt/NF-kappaB signaling pathway.
    Oncol Rep. 2017 Feb 14. doi: 10.3892/or.2017.5453.
    PubMed     Text format     Abstract available


  5. CHAI Y, Xu J, Yan B
    The anti-metastatic effect of baicalein on colorectal cancer.
    Oncol Rep. 2017 Feb 10. doi: 10.3892/or.2017.5437.
    PubMed     Text format     Abstract available


    January 2017
  6. SAETANG J, Sangkhathat S
    Diets link metabolic syndrome and colorectal cancer development (Review).
    Oncol Rep. 2017 Jan 18. doi: 10.3892/or.2017.5385.
    PubMed     Text format     Abstract available


  7. CHEN Y, Zhang Y, He J, Fu Y, et al
    MicroRNA-133b is regulated by TAp63 while no gene mutation is present in colorectal cancer.
    Oncol Rep. 2017 Jan 16. doi: 10.3892/or.2017.5371.
    PubMed     Text format     Abstract available


  8. WANG H, Chen Z, Chang H, Mu X, et al
    Expression of glia maturation factor gamma is associated with colorectal cancer metastasis and its downregulation suppresses colorectal cancer cell migration and invasion in vitro.
    Oncol Rep. 2017 Jan 9. doi: 10.3892/or.2017.5361.
    PubMed     Text format     Abstract available


  9. JANOWSKI E, Timofeeva O, Chasovskikh S, Goldberg M, et al
    Yttrium-90 radioembolization for colorectal cancer liver metastases in KRAS wild-type and mutant patients: Clinical and ccfDNA studies.
    Oncol Rep. 2017;37:57-65.
    PubMed     Text format     Abstract available


  10. HUANG G, Chen X, Cai Y, Wang X, et al
    miR-20a-directed regulation of BID is associated with the TRAIL sensitivity in colorectal cancer.
    Oncol Rep. 2017;37:571-578.
    PubMed     Text format     Abstract available


    December 2016
  11. FUJIYOSHI K, Yamamoto G, Takahashi A, Arai Y, et al
    High concordance rate of KRAS/BRAF mutations and MSI-H between primary colorectal cancer and corresponding metastases.
    Oncol Rep. 2016 Dec 15. doi: 10.3892/or.2016.5323.
    PubMed     Text format     Abstract available


  12. WANG T, Ning K, Lu TX, Hua D, et al
    Elevated expression of TrpC5 and GLUT1 is associated with chemoresistance in colorectal cancer.
    Oncol Rep. 2016 Dec 15. doi: 10.3892/or.2016.5322.
    PubMed     Text format     Abstract available


  13. ZHANG C, Gong P, Liu P, Zhou N, et al
    Thioridazine elicits potent antitumor effects in colorectal cancer stem cells.
    Oncol Rep. 2016 Dec 14. doi: 10.3892/or.2016.5313.
    PubMed     Text format     Abstract available


    November 2016
  14. KIJIMA T, Hazama S, Tsunedomi R, Tanaka H, et al
    MicroRNA-6826 and -6875 in plasma are valuable noninvasive biomarkers that predict the efficacy of vaccine treatment against metastatic colorectal cancer.
    Oncol Rep. 2016 Nov 22. doi: 10.3892/or.2016.5267.
    PubMed     Text format     Abstract available


  15. MIYO M, Konno M, Colvin H, Nishida N, et al
    The importance of mitochondrial folate enzymes in human colorectal cancer.
    Oncol Rep. 2016 Nov 22. doi: 10.3892/or.2016.5264.
    PubMed     Text format     Abstract available


  16. FU Q, Cheng J, Zhang J, Zhang Y, et al
    miR-20b reduces 5-FU resistance by suppressing the ADAM9/EGFR signaling pathway in colon cancer.
    Oncol Rep. 2016 Nov 18. doi: 10.3892/or.2016.5259.
    PubMed     Text format     Abstract available


  17. JIANG D, Wang L, Zhao T, Zhang Z, et al
    Restoration of the tumor-suppressor function to mutant p53 by Ganoderma lucidum polysaccharides in colorectal cancer cells.
    Oncol Rep. 2016 Nov 15. doi: 10.3892/or.2016.5246.
    PubMed     Text format     Abstract available


  18. WEN W, Liu G, Jin K, Hu X, et al
    TGF-beta1 induces PGP9.5 expression in CAFs to promote the growth of colorectal cancer cells.
    Oncol Rep. 2016 Nov 9. doi: 10.3892/or.2016.5238.
    PubMed     Text format     Abstract available


  19. ZHAO M, Yu Z, Li Z, Tang J, et al
    Expression of angiogenic growth factors VEGF, bFGF and ANG1 in colon cancer after bevacizumab treatment in vitro: A potential self-regulating mechanism.
    Oncol Rep. 2016 Nov 8. doi: 10.3892/or.2016.5231.
    PubMed     Text format     Abstract available


  20. LIU N, Li J, Zhao Z, Han J, et al
    MicroRNA-302a enhances 5-fluorouracil-induced cell death in human colon cancer cells.
    Oncol Rep. 2016 Nov 8. doi: 10.3892/or.2016.5237.
    PubMed     Text format     Abstract available


  21. ONOZAWA H, Saito M, Saito K, Kanke Y, et al
    Annexin A1 is involved in resistance to 5-FU in colon cancer cells.
    Oncol Rep. 2016 Nov 8. doi: 10.3892/or.2016.5234.
    PubMed     Text format     Abstract available


  22. ZHAO J, Lv Y, Cai Y, Wei W, et al
    Hyperthermic carbon dioxide pneumoperitoneum reinforces the inhibition of 5-FU on the proliferation and invasion of colon cancer.
    Oncol Rep. 2016 Nov 8. doi: 10.3892/or.2016.5229.
    PubMed     Text format     Abstract available


  23. HUANG HL, Chen WC, Hsu HP, Cho CY, et al
    Silencing of argininosuccinate lyase inhibits colorectal cancer formation.
    Oncol Rep. 2016 Nov 7. doi: 10.3892/or.2016.5221.
    PubMed     Text format     Abstract available


  24. KIM DH, Kim MJ, Sung B, Suh H, et al
    Resveratrol analogue, HS-1793, induces apoptotic cell death and cell cycle arrest through downregulation of AKT in human colon cancer cells.
    Oncol Rep. 2016 Nov 7. doi: 10.3892/or.2016.5219.
    PubMed     Text format     Abstract available


  25. LEE CY, Hsieh SL, Hsieh S, Tsai CC, et al
    Inhibition of human colorectal cancer metastasis by notoginsenoside R1, an important compound from Panax notoginseng.
    Oncol Rep. 2016 Nov 7. doi: 10.3892/or.2016.5222.
    PubMed     Text format     Abstract available


  26. GAO L, Zhou Y, Zhou SX, Yu XJ, et al
    PLD4 promotes M1 macrophages to perform antitumor effects in colon cancer cells.
    Oncol Rep. 2016 Nov 3. doi: 10.3892/or.2016.5216.
    PubMed     Text format     Abstract available


  27. WANG C, Guo D, Wang Q, You S, et al
    Aliskiren targets multiple systems to alleviate cancer cachexia.
    Oncol Rep. 2016;36:3014-3022.
    PubMed     Text format     Abstract available


  28. ZHOU X, Xing X, Zhang S, Liu L, et al
    Glucose-regulated protein 78 contributes to the proliferation and tumorigenesis of human colorectal carcinoma via AKT and ERK pathways.
    Oncol Rep. 2016;36:2723-2730.
    PubMed     Text format     Abstract available


  29. YASSIN S, Hu J, Xu H, Li C, et al
    In vitro and in vivo activities of an antitumor peptide HM-3: A special dose-efficacy relationship on an HCT116 xenograft model in nude mice.
    Oncol Rep. 2016;36:2951-2959.
    PubMed     Text format     Abstract available


  30. LAGERSTEDT-ROBINSON K, Rohlin A, Aravidis C, Melin B, et al
    Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population.
    Oncol Rep. 2016;36:2823-2835.
    PubMed     Text format     Abstract available


    October 2016
  31. SUZUKI N, Nakagawa F, Matsuoka K, Takechi T, et al
    Effect of a novel oral chemotherapeutic agent containing a combination of trifluridine, tipiracil and the novel triple angiokinase inhibitor nintedanib, on human colorectal cancer xenografts.
    Oncol Rep. 2016 Oct 27. doi: 10.3892/or.2016.5208.
    PubMed     Text format     Abstract available


  32. WU H, Cheng X, Ji X, He Y, et al
    Cortactin contributes to the tumorigenicity of colorectal cancer by promoting cell proliferation.
    Oncol Rep. 2016 Oct 27. doi: 10.3892/or.2016.5207.
    PubMed     Text format     Abstract available


  33. RIFFO-CAMPOS AL, Castillo J, Vallet-Sanchez A, Ayala G, et al
    In silico RNA-seq and experimental analyses reveal the differential expression and splicing of EPDR1 and ZNF518B genes in relation to KRAS mutations in colorectal cancer cells.
    Oncol Rep. 2016 Oct 27. doi: 10.3892/or.2016.5210.
    PubMed     Text format     Abstract available


  34. TAKATSUNA M, Morohashi S, Yoshizawa T, Hirai H, et al
    Myofibroblast distribution is associated with invasive growth types of colorectal cancer.
    Oncol Rep. 2016 Oct 25. doi: 10.3892/or.2016.5202.
    PubMed     Text format     Abstract available


  35. FU Q, Cheng J, Zhang J, Zhang Y, et al
    Downregulation of YEATS4 by miR-218 sensitizes colorectal cancer cells to L-OHP-induced cell apoptosis by inhibiting cytoprotective autophagy.
    Oncol Rep. 2016 Oct 21. doi: 10.3892/or.2016.5195.
    PubMed     Text format     Abstract available


  36. WANG L, Yu P
    miR-300 promotes proliferation and EMT-mediated colorectal cancer migration and invasion by targeting p53.
    Oncol Rep. 2016 Oct 21. doi: 10.3892/or.2016.5193.
    PubMed     Text format     Abstract available


  37. ZHANG Y, Yuan J, Zhang X, Yan F, et al
    Angiomotin promotes the malignant potential of colon cancer cells by activating the YAP-ERK/PI3K-AKT signaling pathway.
    Oncol Rep. 2016 Oct 21. doi: 10.3892/or.2016.5194.
    PubMed     Text format     Abstract available


  38. LIN J, Feng J, Jin Y, Yan Z, et al
    Pien Tze Huang suppresses VEGF-C-mediated lymphangiogenesis in colorectal cancer.
    Oncol Rep. 2016 Oct 20. doi: 10.3892/or.2016.5186.
    PubMed     Text format     Abstract available


  39. MARLICZ W, Sielatycka K, Serwin K, Kubis E, et al
    Effect of colorectal cancer on the number of normal stem cells circulating in peripheral blood.
    Oncol Rep. 2016 Oct 18. doi: 10.3892/or.2016.5179.
    PubMed     Text format     Abstract available


  40. ZHOU X, Wang P, Zhang YJ, Xu JJ, et al
    Comparative proteomic analysis of melanosis coli with colon cancer.
    Oncol Rep. 2016 Oct 17. doi: 10.3892/or.2016.5178.
    PubMed     Text format     Abstract available


  41. YI W, Xiao E, Ding R, Luo P, et al
    High expression of fibronectin is associated with poor prognosis, cell proliferation and malignancy via the NF-kappaB/p53-apoptosis signaling pathway in colorectal cancer.
    Oncol Rep. 2016 Oct 17. doi: 10.3892/or.2016.5177.
    PubMed     Text format     Abstract available


  42. ZHANG H, Qiao L, Li X, Wan Y, et al
    Tissue metabolic profiling of lymph node metastasis of colorectal cancer assessed by 1H NMR.
    Oncol Rep. 2016 Oct 14. doi: 10.3892/or.2016.5175.
    PubMed     Text format     Abstract available


  43. CHEN F, Sun G, Peng J
    RNAi-mediated HOXD3 knockdown inhibits growth in human RKO cells.
    Oncol Rep. 2016;36:1793-8.
    PubMed     Text format     Abstract available


  44. TIAN X, Yan L, Zhang D, Guan X, et al
    PTK7 overexpression in colorectal tumors: Clinicopathological correlation and prognosis relevance.
    Oncol Rep. 2016;36:1829-36.
    PubMed     Text format     Abstract available


    September 2016
  45. FAN XJ, Wang Y, Wang L, Zhu M, et al
    Salidroside induces apoptosis and autophagy in human colorectal cancer cells through inhibition of PI3K/Akt/mTOR pathway.
    Oncol Rep. 2016 Sep 30. doi: 10.3892/or.2016.5138.
    PubMed     Text format     Abstract available


  46. HOLZNER S, Senfter D, Stadler S, Staribacher A, et al
    Colorectal cancer cell-derived microRNA200 modulates the resistance of adjacent blood endothelial barriers in vitro.
    Oncol Rep. 2016 Sep 20. doi: 10.3892/or.2016.5114.
    PubMed     Text format     Abstract available


  47. HUANG C, Liu H, Gong XL, Wu L, et al
    Expression of DNA methyltransferases and target microRNAs in human tissue samples related to sporadic colorectal cancer.
    Oncol Rep. 2016 Sep 19. doi: 10.3892/or.2016.5104.
    PubMed     Text format     Abstract available


  48. YOO HI, Kim BK, Yoon SK
    MicroRNA-330-5p negatively regulates ITGA5 expression in human colorectal cancer.
    Oncol Rep. 2016 Sep 15. doi: 10.3892/or.2016.5092.
    PubMed     Text format     Abstract available


  49. KIM BR, Kang MH, Kim JL, Na YJ, et al
    RUNX3 inhibits the metastasis and angiogenesis of colorectal cancer.
    Oncol Rep. 2016 Sep 12. doi: 10.3892/or.2016.5086.
    PubMed     Text format     Abstract available


    August 2016
  50. JING X, Wu H, Ji X, Wu H, et al
    Cortactin promotes cell migration and invasion through upregulation of the dedicator of cytokinesis 1 expression in human colorectal cancer.
    Oncol Rep. 2016 Aug 31. doi: 10.3892/or.2016.5058.
    PubMed     Text format     Abstract available


  51. LI S, Wu X, Xu Y, Wu S, et al
    miR-145 suppresses colorectal cancer cell migration and invasion by targeting an ETS-related gene.
    Oncol Rep. 2016 Aug 25. doi: 10.3892/or.2016.5042.
    PubMed     Text format     Abstract available


  52. WU Y, Xie R, Liu X, Wang J, et al
    Knockdown of FOXK1 alone or in combination with apoptosis-inducing 5-FU inhibits cell growth in colorectal cancer.
    Oncol Rep. 2016 Aug 25. doi: 10.3892/or.2016.5041.
    PubMed     Text format     Abstract available


  53. ZHANG SS, Huang ZW, Li LX, Fu JJ, et al
    Identification of CD200+ colorectal cancer stem cells and their gene expression profile.
    Oncol Rep. 2016 Aug 24. doi: 10.3892/or.2016.5039.
    PubMed     Text format     Abstract available


  54. RUWAN KUMARA MH, Piao MJ, Kang KA, Ryu YS, et al
    Non-thermal gas plasma-induced endoplasmic reticulum stress mediates apoptosis in human colon cancer cells.
    Oncol Rep. 2016 Aug 24. doi: 10.3892/or.2016.5038.
    PubMed     Text format     Abstract available


  55. ACQUAVIVA R, Sorrenti V, Santangelo R, Cardile V, et al
    Effects of an extract of Celtis aetnensis (Tornab.) Strobl twigs on human colon cancer cell cultures.
    Oncol Rep. 2016 Aug 24. doi: 10.3892/or.2016.5035.
    PubMed     Text format     Abstract available


  56. XIONG W, Gao D, Li Y, Liu X, et al
    Genome-wide profiling of chemoradiationinduced changes in alternative splicing in colon cancer cells.
    Oncol Rep. 2016 Aug 12. doi: 10.3892/or.2016.5022.
    PubMed     Text format     Abstract available


  57. OKADA K, Hakata S, Terashima J, Gamou T, et al
    Combination of the histone deacetylase inhibitor depsipeptide and 5-fluorouracil upregulates major histocompatibility complex class II and p21 genes and activates caspase-3/7 in human colon cancer HCT-116 cells.
    Oncol Rep. 2016 Aug 8. doi: 10.3892/or.2016.5008.
    PubMed     Text format     Abstract available


    July 2016
  58. XU K, Wang J, Gao J, Di J, et al
    GATA binding protein 2 overexpression is associated with poor prognosis in KRAS mutant colorectal cancer.
    Oncol Rep. 2016 Jul 21. doi: 10.3892/or.2016.4961.
    PubMed     Text format     Abstract available


  59. XU W, Xu B, Yao Y, Yu X, et al
    RNA interference against TRIM29 inhibits migration and invasion of colorectal cancer cells.
    Oncol Rep. 2016 Jul 15. doi: 10.3892/or.2016.4941.
    PubMed     Text format     Abstract available


  60. WEI H, Cheng Z, Ouyang C, Zhang Y, et al
    Glycoprotein screening in colorectal cancer based on differentially expressed Tn antigen.
    Oncol Rep. 2016 Jul 14. doi: 10.3892/or.2016.4937.
    PubMed     Text format     Abstract available


  61. TAKATSUNA M, Morohashi S, Yoshizawa T, Hirai H, et al
    Myofibroblasts of the muscle layer stimulate the malignant potential of colorectal cancer.
    Oncol Rep. 2016 Jul 11. doi: 10.3892/or.2016.4932.
    PubMed     Text format     Abstract available


  62. ZHU L, Tian G, Yang Q, De G, et al
    Thyroid hormone receptor beta1 suppresses proliferation and migration by inhibiting PI3K/Akt signaling in human colorectal cancer cells.
    Oncol Rep. 2016 Jul 11. doi: 10.3892/or.2016.4931.
    PubMed     Text format     Abstract available


  63. LIANG L, Huang J
    Oxymatrine inhibits epithelial-mesenchymal transition through regulation of NF-kappaB signaling in colorectal cancer cells.
    Oncol Rep. 2016 Jul 11. doi: 10.3892/or.2016.4927.
    PubMed     Text format     Abstract available


  64. SUN ZZ, Zhang T, Ning K, Zhu R, et al
    B7-H3 upregulates BRCC3 expression, antagonizing DNA damage caused by 5-Fu.
    Oncol Rep. 2016;36:231-8.
    PubMed     Text format     Abstract available


  65. ZHANG Y, Lin L, Jin Y, Lin Y, et al
    Overexpression of WNT5B promotes COLO 205 cell migration and invasion through the JNK signaling pathway.
    Oncol Rep. 2016;36:23-30.
    PubMed     Text format     Abstract available


    June 2016
  66. IWAI T, Sugimoto M, Harada S, Yorozu K, et al
    Continuous administration of bevacizumab plus capecitabine, even after acquired resistance to bevacizumab, restored anti-angiogenic and antitumor effect in a human colorectal cancer xenograft model.
    Oncol Rep. 2016 Jun 22. doi: 10.3892/or.2016.4902.
    PubMed     Text format     Abstract available


  67. KIM EH, Lee H, Jeong YK, Jung WG, et al
    Mechanisms of SU5416, an inhibitor of vascular endothelial growth factor receptor, as a radiosensitizer for colon cancer cells.
    Oncol Rep. 2016 Jun 10. doi: 10.3892/or.2016.4868.
    PubMed     Text format     Abstract available


  68. LIU J, Li Q, Liu Z, Lin L, et al
    Harmine induces cell cycle arrest and mitochondrial pathway-mediated cellular apoptosis in SW620 cells via inhibition of the Akt and ERK signaling pathways.
    Oncol Rep. 2016;35:3363-70.
    PubMed     Text format     Abstract available


    May 2016
  69. KANG HR, Choi HG, Jeon CK, Lim SJ, et al
    Butyrate-mediated acquisition of chemoresistance by human colon cancer cells.
    Oncol Rep. 2016 May 27. doi: 10.3892/or.2016.4838.
    PubMed     Text format     Abstract available


  70. CUI F, Wang S, Lao I, Zhou C, et al
    miR-375 inhibits the invasion and metastasis of colorectal cancer via targeting SP1 and regulating EMT-associated genes.
    Oncol Rep. 2016 May 24. doi: 10.3892/or.2016.4834.
    PubMed     Text format     Abstract available


  71. LEE MH, Hong SH, Park C, Kim GY, et al
    Hwang-Heuk-San induces apoptosis in HCT116 human colorectal cancer cells through the ROS-mediated activation of caspases and the inactivation of the PI3K/Akt signaling pathway.
    Oncol Rep. 2016 May 17. doi: 10.3892/or.2016.4812.
    PubMed     Text format     Abstract available


  72. HAN J, Liu Z, Wang N, Pan W, et al
    MicroRNA-874 inhibits growth, induces apoptosis and reverses chemoresistance in colorectal cancer by targeting X-linked inhibitor of apoptosis protein.
    Oncol Rep. 2016 May 16. doi: 10.3892/or.2016.4810.
    PubMed     Text format     Abstract available


  73. ZHA H, Sun H, Li X, Duan L, et al
    S100A8 facilitates the migration of colorectal cancer cells through regulating macrophages in the inflammatory microenvironment.
    Oncol Rep. 2016 May 6. doi: 10.3892/or.2016.4790.
    PubMed     Text format     Abstract available


  74. SHOJI H, Motegi M, Osawa K, Okonogi N, et al
    Radiofrequency thermal treatment with chemoradiotherapy for advanced rectal cancer.
    Oncol Rep. 2016;35:2569-75.
    PubMed     Text format     Abstract available


    April 2016
  75. WU QX, Yuan SX, Ren CM, Yu Y, et al
    Oridonin upregulates PTEN through activating p38 MAPK and inhibits proliferation in human colon cancer cells.
    Oncol Rep. 2016 Apr 7. doi: 10.3892/or.2016.4735.
    PubMed     Text format     Abstract available


  76. PONNUSAMY S, Lattmann E, Lattmann P, Thiyagarajan T, et al
    Novel, isoform-selective, cholecystokinin A receptor antagonist inhibits colon and pancreatic cancers in preclinical models through novel mechanism of action.
    Oncol Rep. 2016;35:2097-106.
    PubMed     Text format     Abstract available


    March 2016
  77. KIM N, Cho SB, Park YL, Park SY, et al
    Effect of Recepteur d'Origine Nantais expression on chemosensitivity and tumor cell behavior in colorectal cancer.
    Oncol Rep. 2016 Mar 31. doi: 10.3892/or.2016.4721.
    PubMed     Text format     Abstract available


  78. HUANG G, Cheng J, Yu F, Liu X, et al
    Clinical and therapeutic significance of sirtuin-4 expression in colorectal cancer.
    Oncol Rep. 2016 Mar 17. doi: 10.3892/or.2016.4685.
    PubMed     Text format     Abstract available


  79. ZHANG Z, Chen H, Xu C, Song L, et al
    Curcumin inhibits tumor epithelialmesenchymal transition by downregulating the Wnt signaling pathway and upregulating NKD2 expression in colon cancer cells.
    Oncol Rep. 2016 Mar 10. doi: 10.3892/or.2016.4669.
    PubMed     Text format     Abstract available


  80. LI J, Wang SW, Zhang DS, Sun Y, et al
    FTY720-induced enhancement of autophagy protects cells from FTY720 cytotoxicity in colorectal cancer.
    Oncol Rep. 2016 Mar 9. doi: 10.3892/or.2016.4668.
    PubMed     Text format     Abstract available


  81. REN CM, Li Y, Chen QZ, Zeng YH, et al
    Oridonin inhibits the proliferation of human colon cancer cells by upregulating BMP7 to activate p38 MAPK.
    Oncol Rep. 2016 Mar 7. doi: 10.3892/or.2016.4654.
    PubMed     Text format     Abstract available


  82. KIM A, Im M, Ma JY
    Sosihotang ameliorates cachexiarelated symptoms in mice bearing colon 26 adenocarcinoma by reducing systemic inflammation and muscle loss.
    Oncol Rep. 2016;35:1841-50.
    PubMed     Text format     Abstract available


    February 2016
  83. BI DP, Yin CH, Zhang XY, Yang NN, et al
    miR-183 functions as an oncogene by targeting ABCA1 in colon cancer.
    Oncol Rep. 2016 Feb 23. doi: 10.3892/or.2016.4631.
    PubMed     Text format     Abstract available


  84. QU H, Yin H, Yan S, Tao M, et al
    Inhibitor of growth 4 suppresses colorectal cancer growth and invasion by inducing G1 arrest, inhibiting tumor angiogenesis and reversing epithelial-mesenchymal transition.
    Oncol Rep. 2016 Feb 18. doi: 10.3892/or.2016.4626.
    PubMed     Text format     Abstract available


  85. TSENG A, Yang CH, Chen CH, Chen CH, et al
    An in vivo molecular response analysis of colorectal cancer treated with Astragalus membranaceus extract.
    Oncol Rep. 2016;35:659-668.
    PubMed     Text format     Abstract available


  86. XIANG T, Yu F, Fei R, Qian J, et al
    CHRNA7 inhibits cell invasion and metastasis of LoVo human colorectal cancer cells through PI3K/Akt signaling.
    Oncol Rep. 2016;35:999-1005.
    PubMed     Text format     Abstract available


  87. ZHAO D, Sui Y, Zheng X
    miR-331-3p inhibits proliferation and promotes apoptosis by targeting HER2 through the PI3K/Akt and ERK1/2 pathways in colorectal cancer.
    Oncol Rep. 2016;35:1075-1082.
    PubMed     Text format     Abstract available


  88. JIA Y, Zhang S, Miao L, Wang J, et al
    [Corrigendum] Activation of platelet protease-activated receptor-1 induces epithelial-mesenchymal transition and chemotaxis of colon cancer cell line SW620.
    Oncol Rep. 2016;35:1222.
    PubMed     Text format     Abstract available


  89. ZHAO J, Cai Y, Yin C, Lv Y, et al
    Study on the inhibition of hyperthermic CO2 pneumoperitoneum on the proliferation and migration of colon cancer cells and its mechanism.
    Oncol Rep. 2016;35:985-991.
    PubMed     Text format     Abstract available


  90. YOUSEF BA, Guerram M, Hassan HM, Hamdi AM, et al
    Pristimerin demonstrates anticancer potential in colorectal cancer cells by inducing G1 phase arrest and apoptosis and suppressing various pro-survival signaling proteins.
    Oncol Rep. 2016;35:1091-1100.
    PubMed     Text format     Abstract available


  91. HUANG W, Liu Z, Zhou G, Tian A, et al
    Magnetic gold nanoparticle-mediated small interference RNA silencing Bag-1 gene for colon cancer therapy.
    Oncol Rep. 2016;35:978-984.
    PubMed     Text format     Abstract available


  92. LUO J, Xu L, Jiang Y, Zhuo D, et al
    Expression profile of long non-coding RNAs in colorectal cancer: A microarray analysis.
    Oncol Rep. 2016 Feb 1. doi: 10.3892/or.2016.4606.
    PubMed     Text format     Abstract available


  93. YORIFUJI N, Inoue T, Iguchi M, Fujiwara K, et al
    The dipeptidyl peptidase-4 inhibitor sitagliptin suppresses mouse colon tumorigenesis in type 2 diabetic mice.
    Oncol Rep. 2016;35:676-82.
    PubMed     Text format     Abstract available


    January 2016
  94. ZHENG YM, Lu AX, Shen JZ, Kwok AH, et al
    Imperatorin exhibits anticancer activities in human colon cancer cells via the caspase cascade.
    Oncol Rep. 2016 Jan 21. doi: 10.3892/or.2016.4586.
    PubMed     Text format     Abstract available


  95. LI Z, Wang H, Xu Z, Sun Y, et al
    Expression and mechanism of microRNA-181A on incidence and survival in late liver metastases of colorectal cancer.
    Oncol Rep. 2016 Jan 5. doi: 10.3892/or.2016.4546.
    PubMed     Text format     Abstract available


  96. KASAI C, Sugimoto K, Moritani I, Tanaka J, et al
    Comparison of human gut microbiota in control subjects and patients with colorectal carcinoma in adenoma: Terminal restriction fragment length polymorphism and next-generation sequencing analyses.
    Oncol Rep. 2016;35:325-33.
    PubMed     Text format     Abstract available


  97. WENG WH, Leung WH, Pang YJ, Hsu HH, et al
    Lauric acid can improve the sensitization of Cetuximab in KRAS/BRAF mutated colorectal cancer cells by retrievable microRNA-378 expression.
    Oncol Rep. 2016;35:107-16.
    PubMed     Text format     Abstract available


    December 2015
  98. WU R, Chen Y, Li F, Li W, et al
    Effects of CD73 on human colorectal cancer cell growth in vivo and in vitro.
    Oncol Rep. 2015 Dec 23. doi: 10.3892/or.2015.4512.
    PubMed     Text format     Abstract available


  99. CHE XH, Chen CL, Ye XL, Weng GB, et al
    Dual inhibition of COX-2/5-LOX blocks colon cancer proliferation, migration and invasion in vitro.
    Oncol Rep. 2015 Dec 22. doi: 10.3892/or.2015.4506.
    PubMed     Text format     Abstract available


  100. LI J, Teng Y, Liu S, Wang Z, et al
    Cinnamaldehyde affects the biological behavior of human colorectal cancer cells and induces apoptosis via inhibition of the PI3K/Akt signaling pathway.
    Oncol Rep. 2015 Dec 17. doi: 10.3892/or.2015.4493.
    PubMed     Text format     Abstract available


  101. AL-KHAYAL K, Abdulla M, Al-Obeed O, Al Kattan W, et al
    Identification of the TP53-induced glycolysis and apoptosis regulator in various stages of colorectal cancer patients.
    Oncol Rep. 2015 Dec 17. doi: 10.3892/or.2015.4494.
    PubMed     Text format     Abstract available


  102. IHARA K, Yamaguchi S, Ueno N, Tani Y, et al
    Expression of DNA double-strand break repair proteins predicts the response and prognosis of colorectal cancer patients undergoing oxaliplatin-based chemotherapy.
    Oncol Rep. 2015 Dec 16. doi: 10.3892/or.2015.4488.
    PubMed     Text format     Abstract available


  103. MARQUEZ J, Mena J, Hernandez-Unzueta I, Benedicto A, et al
    Ocoxin(R) oral solution slows down tumor growth in an experimental model of colorectal cancer metastasis to the liver in Balb/c mice.
    Oncol Rep. 2015 Dec 16. doi: 10.3892/or.2015.4486.
    PubMed     Text format     Abstract available


  104. QIAN K, Zhang J, Lu J, Liu W, et al
    FAM172A modulates apoptosis and proliferation of colon cancer cells via STAT1 binding to its promoter.
    Oncol Rep. 2015 Dec 10. doi: 10.3892/or.2015.4485.
    PubMed     Text format     Abstract available


  105. YANG Y, Luo H, Hui K, Ci Y, et al
    Selenite-induced autophagy antagonizes apoptosis in colorectal cancer cells in vitro and in vivo.
    Oncol Rep. 2015 Dec 10. doi: 10.3892/or.2015.4484.
    PubMed     Text format     Abstract available


  106. ZHANG B, Leng C, Wu C, Zhang Z, et al
    Smad4 sensitizes colorectal cancer to 5-fluorouracil through cell cycle arrest by inhibiting the PI3K/Akt/CDC2/survivin cascade.
    Oncol Rep. 2015 Dec 8. doi: 10.3892/or.2015.4479.
    PubMed     Text format     Abstract available


    November 2015
  107. YUAN SX, Wang DX, Wu QX, Ren CM, et al
    BMP9/p38 MAPK is essential for the antiproliferative effect of resveratrol on human colon cancer.
    Oncol Rep. 2015 Nov 10. doi: 10.3892/or.2015.4407.
    PubMed     Text format     Abstract available


  108. YANG XD, Xu HT, Xu XH, Ru G, et al
    Knockdown of long non-coding RNA HOTAIR inhibits proliferation and invasiveness and improves radiosensitivity in colorectal cancer.
    Oncol Rep. 2015 Nov 4. doi: 10.3892/or.2015.4397.
    PubMed     Text format     Abstract available


  109. QI F, Wei L, Shen A, Chen Y, et al
    Pien Tze Huang inhibits the proliferation, and induces the apoptosis and differentiation of colorectal cancer stem cells via suppression of the Notch1 pathway.
    Oncol Rep. 2015 Nov 2. doi: 10.3892/or.2015.4378.
    PubMed     Text format     Abstract available


    October 2015
  110. YANG L, Qiu M, Xu Y, Wang J, et al
    Upregulation of long non-coding RNA PRNCR1 in colorectal cancer promotes cell proliferation and cell cycle progression.
    Oncol Rep. 2015 Oct 30. doi: 10.3892/or.2015.4364.
    PubMed     Text format     Abstract available


  111. XIANG T, Fei R, Wang Z, Shen Z, et al
    Nicotine enhances invasion and metastasis of human colorectal cancer cells through the nicotinic acetylcholine receptor downstream p38 MAPK signaling pathway.
    Oncol Rep. 2015 Oct 30. doi: 10.3892/or.2015.4363.
    PubMed     Text format     Abstract available


  112. DU C, Wang X, Zhang J, Liu X, et al
    Paxillin is positively correlated with the clinicopathological factors of colorectal cancer, and knockdown of Paxillin improves sensitivity to cetuximab in colorectal cancer cells.
    Oncol Rep. 2015 Oct 27. doi: 10.3892/or.2015.4352.
    PubMed     Text format     Abstract available


    August 2015
  113. FANG H, Kang J, Du R, Zhao X, et al
    Growth inhibitory effect of adenovirus-mediated tissue-targeted expression of ribosomal protein L23 on human colorectal carcinoma cells.
    Oncol Rep. 2015;34:763-70.
    PubMed     Text format     Abstract available


    July 2015
  114. KIM JS, Son Y, Bae MJ, Lee M, et al
    Administration of granulocyte colony-stimulating factor with radiotherapy promotes tumor growth by stimulating vascularization in tumor-bearing mice.
    Oncol Rep. 2015;34:147-54.
    PubMed     Text format     Abstract available


    June 2015
  115. ATSUMI J, Hanami T, Enokida Y, Ogawa H, et al
    Eprobe-mediated screening system for somatic mutations in the KRAS locus.
    Oncol Rep. 2015;33:2719-27.
    PubMed     Text format     Abstract available


    May 2015
  116. JI M, Lee EJ, Kim KB, Kim Y, et al
    HDAC inhibitors induce epithelial-mesenchymal transition in colon carcinoma cells.
    Oncol Rep. 2015;33:2299-308.
    PubMed     Text format     Abstract available


    April 2015
  117. INOUE T, Yorifuji N, Iguchi M, Fujiwara K, et al
    Geranylgeranylacetone suppresses colitisrelated mouse colon carcinogenesis.
    Oncol Rep. 2015;33:1769-74.
    PubMed     Text format     Abstract available


  118. HASHIMI SM, Xu T, Wei MQ
    Violacein anticancer activity is enhanced under hypoxia.
    Oncol Rep. 2015;33:1731-6.
    PubMed     Text format     Abstract available


  119. SONG J, Liu H, Li Z, Yang C, et al
    Cucurbitacin I inhibits cell migration and invasion and enhances chemosensitivity in colon cancer.
    Oncol Rep. 2015;33:1867-71.
    PubMed     Text format     Abstract available


    March 2015
  120. JIKIHARA H, Qi G, Nozoe K, Hirokawa M, et al
    Aged garlic extract inhibits 1,2-dimethylhydrazine-induced colon tumor development by suppressing cell proliferation.
    Oncol Rep. 2015;33:1131-40.
    PubMed     Text format     Abstract available


  121. XIANG S, Fang J, Wang S, Deng B, et al
    MicroRNA135b regulates the stability of PTEN and promotes glycolysis by targeting USP13 in human colorectal cancers.
    Oncol Rep. 2015;33:1342-8.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: